Dekk-Tec, Inc. (DekkTec)

Oncology Corporate Profile

HQ Location

New Orleans, LA

Company Description

EKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for the treatment of cancer, pre-cancerous lesions, and women's health issues. We have previously licensed two of our pipeline products to Biotech/Pharmaceutical companies who have successfully driven these compounds into Phase II clinical development. We also have experience with 510K devise submissions. Our present objective is to continue to create and develop new and novel drugs based on our current novel cancer therapeutic agents - DM-CHOC-PEN and hydroperoxy analogs.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
DM-CHOC-PENpenclomidine non-neurotoxic derivativeBrain Metastases

View additional information on product candidates here »


Recent News Headlines

There are no news items to display